• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.《恶病质、肌肉减少症与肌肉杂志》的作者署名及发表伦理准则
J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):7-8. doi: 10.1007/s13539-010-0003-5. Epub 2010 Oct 26.
2
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.《恶病质、肌少症与肌肉杂志》发表伦理准则:2019 年更新版。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145. doi: 10.1002/jcsm.12501.
3
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2023.《恶液质、肌少症与肌肉杂志》发表伦理准则:2023 年更新版。
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2981-2983. doi: 10.1002/jcsm.13420.
4
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.《恶病质、肌肉减少症与肌肉杂志》发表伦理准则:2017 年更新版
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083. doi: 10.1002/jcsm.12261. Epub 2017 Nov 3.
5
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.《恶病质、肌肉减少症与肌肉杂志》发表伦理指南:2015年更新版
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):315-6. doi: 10.1002/jcsm.12089. Epub 2015 Nov 11.
6
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021.《恶病质、肌肉减少症与肌肉杂志》发表伦理准则:2021年更新版
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261. doi: 10.1002/jcsm.12899. Epub 2021 Dec 13.
7
Ethical authorship and publishing.道德作者身份与出版
Int J Cardiol. 2009 Jan 9;131(2):149-50. doi: 10.1016/j.ijcard.2008.11.048. Epub 2008 Nov 28.
8
Adherence to ethical standards in publishing scientific articles: a statement from the International Journal of Cardiology.发表科学文章时应遵守道德标准:《国际心脏病学杂志》的声明。
Int J Cardiol. 2012 Nov 29;161(3):124-5. doi: 10.1016/j.ijcard.2012.10.021. Epub 2012 Oct 27.
9
Ethical issues in biomedical publications.生物医学出版物中的伦理问题。
Hum Fertil (Camb). 2001;4(4):261-6. doi: 10.1080/1464727012000199631.
10
Ethical issues in biomedical publications.生物医学出版物中的伦理问题。
Fertil Steril. 2002 May;77(5):883-8. doi: 10.1016/s0015-0282(02)03076-5.

引用本文的文献

1
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2023.《恶液质、肌少症与肌肉杂志》发表伦理准则:2023 年更新版。
J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2981-2983. doi: 10.1002/jcsm.13420.
2
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021.《恶病质、肌肉减少症与肌肉杂志》发表伦理准则:2021年更新版
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261. doi: 10.1002/jcsm.12899. Epub 2021 Dec 13.
3
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.《恶病质、肌少症与肌肉杂志》发表伦理准则:2019 年更新版。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145. doi: 10.1002/jcsm.12501.
4
Response to: "The use of ultrasound for the estimation of muscle mass: one site fits most?".对《超声用于肌肉量评估:一个部位就足够吗?》的回应
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):627-628. doi: 10.1002/jcsm.12293. Epub 2018 Mar 23.
5
Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation.通过下调 SIRT3,骨质疏松症药物阿仑膦酸钠在体外和肌肉疾病模型中预防肌肉减少症。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):585-602. doi: 10.1002/jcsm.12289. Epub 2018 Mar 6.
6
Silver linings on the horizon: highlights from the 10th Cachexia Conference.地平线上的一线希望:第十届恶病质会议亮点。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):176-182. doi: 10.1002/jcsm.12290.
7
Uncoupling protein 1 expression in adipocytes derived from skeletal muscle fibro/adipogenic progenitors is under genetic and hormonal control.解偶联蛋白 1 在来源于成肌纤维细胞的脂肪细胞中的表达受遗传和激素的控制。
J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):384-399. doi: 10.1002/jcsm.12277. Epub 2018 Feb 5.
8
Determinants of muscle preservation in individuals with cerebral palsy across the lifespan: a narrative review of the literature.脑性瘫痪患者全生命周期肌肉保护的决定因素:文献综述的叙述性评价。
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):453-464. doi: 10.1002/jcsm.12287. Epub 2018 Feb 2.
9
Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury.曲美他嗪通过减轻他汀类药物引起的骨骼肌损伤来恢复对运动训练的正向适应。
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):106-118. doi: 10.1002/jcsm.12250. Epub 2017 Nov 19.
10
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.《恶病质、肌肉减少症与肌肉杂志》发表伦理准则:2017 年更新版
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083. doi: 10.1002/jcsm.12261. Epub 2017 Nov 3.

本文引用的文献

1
Best Practice Guidelines on Publication Ethics: a publisher's perspective.《出版伦理最佳实践指南:出版商视角》
Int J Clin Pract Suppl. 2007 Jan;61(152):1-26. doi: 10.1111/j.1742-1241.2006.01230.x.

《恶病质、肌肉减少症与肌肉杂志》的作者署名及发表伦理准则

Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.

作者信息

von Haehling Stephan, Morley John E, Coats Andrew J S, Anker Stefan D

出版信息

J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):7-8. doi: 10.1007/s13539-010-0003-5. Epub 2010 Oct 26.

DOI:10.1007/s13539-010-0003-5
PMID:21475697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3060648/
Abstract

The principles of ethical authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle (JCSM) are: all authors listed on the manuscript have approved its submission and publication as provided to JCSM;no person who has a right to be recognized as author has been omitted from the list of authors;each author has made an independent material contribution to the work submitted for publication;the submitted work is original and is neither under consideration elsewhere nor has it been published previously in whole or in part other than in abstract form;all original research work is approved by the relevant bodies such as institutional review boards or ethics committees;all conflicts of interest, financial or otherwise, that may affect the authors' ability to present data objectively have been duly declared in the manuscript;the manuscript in its published form will be maintained on the servers of JCSM as a valid publication only as long as all statements in the guidelines on ethical publishing remain true;if any of the aforementioned statements ceases to be true, the authors have a duty to notify the editors of JCSM as soon as possible so that the information available online can be updated and/or the manuscript can be withdrawn.

摘要

《恶病质、肌肉减少症与肌肉杂志》(JCSM)的道德著者身份及发表原则如下:稿件上列出的所有作者均已批准按提交给JCSM的内容进行提交和发表;作者名单中没有遗漏任何有权被认可为作者的人;每位作者都对提交发表的作品做出了独立的实质性贡献;提交的作品是原创的,既未在其他地方审议,也未曾以摘要形式以外的其他形式全文或部分发表过;所有原创研究工作均得到机构审查委员会或伦理委员会等相关机构的批准;所有可能影响作者客观呈现数据能力的利益冲突,无论是财务方面还是其他方面,均已在稿件中正式声明;只要道德发表指南中的所有声明仍然有效,已发表形式的稿件将作为有效出版物保存在JCSM的服务器上;如果上述任何声明不再成立,作者有责任尽快通知JCSM的编辑,以便更新在线可用信息和/或撤回稿件。